PRESS RELEASE published on 09/15/2026 at 07:30, 15 days 20 hours ago Inside Information / Other news releases MaaT Pharma receives negative CHMP trend vote for MaaT013 (Xervyteg) conditional marketing authorization application in Europe. Company vows to explore options for patient access MaaT Pharma CHMP Clinical Benefit Xervyteg Negative Trend
PRESS RELEASE published on 09/15/2026 at 07:30, 15 days 20 hours ago Informations privilégiées / Autres communiqués MaaT Pharma annonce une tendance négative du CHMP pour MaaT013 (Xervyteg®) en Europe. Retour oral révéle préoccupations sur bénéfice clinique et sécurité MaaT Pharma CHMP MaaT013 Xervyteg® Tendance Négative
BRIEF published on 07/24/2026 at 12:17, 2 months 7 days ago Invus Public Equities reduces its stake in MAAT PHARMA Voting Rights Threshold Crossing Transfer Of Shares MaaT Pharma Invus
BRIEF published on 07/24/2026 at 12:17, 2 months 7 days ago Invus Public Equities réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuil Cession D'actions MaaT Pharma Invus
PRESS RELEASE published on 07/24/2026 at 12:12, 2 months 7 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, L.P. pour MAAT PHARMA sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils MaaT Pharma Invus Public Equities
BRIEF published on 07/02/2026 at 18:35, 2 months 29 days ago Situation actuelle des actions et droits de vote de MaaT Pharma Euronext Paris Droits De Vote Biotechnologie Actions MaaT Pharma
BRIEF published on 07/02/2026 at 18:35, 2 months 29 days ago Current status of MaaT Pharma shares and voting rights Euronext Paris Voting Rights Biotechnology Actions MaaT Pharma
PRESS RELEASE published on 07/02/2026 at 18:30, 2 months 29 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital MaaT Pharma publie le nombre total d'actions et de droits de vote au 30 juin 2026 conformément à l'article 223-16 du Règlement Général de l'AMF Droits De Vote Capital Social AMF MaaT Pharma Biotechnologies
BRIEF published on 06/30/2026 at 13:13, 3 months ago La demande d'autorisation de mise sur le marché du MaaT013 de MaaT Pharma subit un revers. Maladie Du Greffon Contre L'hôte MaaT Pharma Décision Du CHMP Application Marketing Appel En Réexamen
BRIEF published on 06/30/2026 at 13:13, 3 months ago MaaT Pharma's Marketing Application for MaaT013 Faces Setback Graft-versus-Host Disease MaaT Pharma CHMP Decision Marketing Application Re-examination Appeal
Published on 10/01/2026 at 01:21, 2 hours 42 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 3 hours 3 minutes ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 4 hours 33 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 7 hours 28 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 12 hours 13 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 23:23, 4 hours 39 minutes ago LM PAY S.A. publishes audited FY 2025 results: EBIT reaches PLN 12.4 million and exceeds preliminary result and guidance
Published on 09/30/2026 at 22:34, 5 hours 29 minutes ago The Change of Date of the Annual Report 2025 Publication
Published on 09/30/2026 at 22:05, 5 hours 58 minutes ago ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
Published on 09/30/2026 at 22:05, 5 hours 58 minutes ago Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 22:05, 5 hours 58 minutes ago Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 18:44, 9 hours 18 minutes ago Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 9 hours 18 minutes ago Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 9 hours 45 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 9 hours 48 minutes ago The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 9 hours 48 minutes ago L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms
